Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

A Verve Therapeutics treatment was found to cut cholesterol levels by more than half—with just one shot. The stock jumped ...

The most high-profile departure will be the biotech’s chief medical officer Maria Koehler, M.D., Ph.D. Story Feb. 14 - Spotlight Therapeutics: The San Francisco gene editor has closed its doors.

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

Good morning, today STAT released our annual STATUS List, which features 50 influential people shaping the future of life ...

Featuring 50 influential people shaping the future of biotech, medicine, health care, policy, and health tech. Explore the ...

The layoffs are scheduled for May 28. — Nkarta, a biotech company, 53 job cuts in South San Francisco. The downsizing occurred on March 31. The job cuts were all described as permanent ...

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up ...

vice president of business development at Clearmind Medicine (CMND), a psychedelic pharmaceutical biotech company focused on development of therapeutics to solve underserved health problems.